However, in pediatric ALL, contradicting results were observed, since CD34 expression was associated with favorable presentation and improved event-free survival38, like in our series of pediatric DLBCL, but also in pediatric T-cell ALL, CD34 expression is associated with poor survival39. Here, CD34 is linked to acute lymphoblastic leukemia.